(Q40076868)

17 September 2017

Immunogenicity of tumor antigens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

history and philosophy of science

28 May 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

28 May 2022

author name string

Campbell DA Jr

2

1 reference

17 September 2017

R. B. Herberman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

D. A. Campbell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

R. K. Oldham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

G. D. Bonnard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

C. C. Ting

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

H. T. Holden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

M. Glaser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

J. Djeu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

R. Oehler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194517

28 May 2022

language of work or name

English

0 references

publication date

1 January 1976

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1976.tb41634.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1976.tb41634.x/fullpdf

28 May 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Annals of the New York Academy of Sciences

28 May 2022

published in

1 reference

17 September 2017

276

1 reference

17 September 2017

26-44

1 reference

In vitro activation of cellular immune response to Gross virus-induced lymphoma

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Specific afferent interference by antiserum of in vivo immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB41634.X

Specificity of cellular immune reactivity to virus-induced tumours.

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Natural Cytotoxic Reactivity of Rat Lymphocytes Against Syngeneic Gross Virus-Induced Lymphoma2

28 May 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

The effect of specific anti-rat thymocyte serum on cell-mediated tumor immunity and other lymphocyte functions

28 May 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

28 May 2022

7

34

2165

Glaser M.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

28 May 2022

12

34

1684

Ting C. C.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

28 May 2022

15

34

1676

Ting C. C.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice

28 May 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus

28 May 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus

28 May 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Heterogeneity of Surface Antigens on Endogenous Type C Virus-Producing Cell Sublines Derived from a Clonal Line of BALB/3T3 Cells

28 May 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

28 May 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells

28 May 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Immunity in the tumor-bearing host and its modification by serum factors

28 May 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Inhibition ofin vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing gross leukemia virus-induced tumors

28 May 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

Brief Communication: In Vitro Inhibition of Cell-Mediated Cytotoxicity Against Syngeneic Friend Virus-Induced Leukemia by Immunoregulatory Alpha Globulin

28 May 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB41634.X

28 May 2022

Identifiers

1 reference

17 September 2017

1 reference